Table 1 Participant Demographics
Variables | Total cohort (n = 104) |
|---|---|
Age, years (mean, range) | 41 (18–74) |
Female sex (%) | 63 (60.6) |
Weight, kg (mean ± std) | 78.67 (18.65) |
Crohn's disease | 68 (65.4) |
Ileal | 16 (23.5) |
Colonic | 14 (20.6) |
Ileo-colonic | 38 (55.9) |
Ulcerative colitis | 36 (34.6) |
Pan-colitis | 23 (63.9) |
Left-sided colitis | 10 (27.8) |
Proctitis | 3 (8.3) |
Median disease duration, years (interquartile range) | 6.00 (2.38–11.21) |
Smoking history (%) | 16 (15.4) |
Combination therapy (%) | 64 (61.5) |
Immunomodulator exposure | |
MTX (%) | 58 (55.8) |
Thiopurine (%) | 22 (21.2) |
Surgery (%) | 29 (27.9) |
Anti-infliximab antibodies (%) | 9 (8.7) |